Cargando…

Evaluation of revised classification criteria for giant cell arteritis and its clinical phenotypes

BACKGROUND: GCA is a systemic vasculitis of the elderly, viewed by many as a disease with multiple and overlapping clinical phenotypes. Retrospective studies have shown differences in clinical presentation between these phenotypes. To reflect the heterogeneity of GCA and novel diagnostic methods, ne...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wiberg, Frans, Naderi, Nazanin, Mohammad, Aladdin J, Turesson, Carl
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2021
Materias:	Clinical Science
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8742823/ https://www.ncbi.nlm.nih.gov/pubmed/33871583 http://dx.doi.org/10.1093/rheumatology/keab353

Ejemplares similares

Epidemiology of biopsy-confirmed giant cell arteritis in southern Sweden—an update on incidence and first prevalence estimate
por: Stamatis, Pavlos, et al.
Publicado: (2021)

Negative associations for fasting blood glucose, cholesterol and triglyceride levels with the development of giant cell arteritis
por: Wadström, Karin, et al.
Publicado: (2020)

Pathogenesis of giant cell arteritis with focus on cellular populations
por: Stamatis, Pavlos, et al.
Publicado: (2022)

Analyses of plasma inflammatory proteins reveal biomarkers predictive of subsequent development of giant cell arteritis: a prospective study
por: Wadström, Karin, et al.
Publicado: (2022)

The effect of clinical features and glucocorticoids on biopsy findings in giant cell arteritis
por: Jakobsson, Karin, et al.
Publicado: (2016)

Comment on: Epidemiology of biopsy-confirmed giant cell arteritis in southern Sweden—an update on incidence and first prevalence estimate: reply
por: Stamatis, Pavlos, et al.
Publicado: (2021)

Can active sun exposure decrease the risk of giant cell arteritis and polymyalgia rheumatica in women?
por: Gisslander, Karl, et al.
Publicado: (2023)

Comment on: Negative associations for fasting blood glucose, cholesterol and triglyceride levels with the development of giant cell arteritis: reply
por: Wadström, Karin, et al.
Publicado: (2021)

Giant cell arteritis: a multicenter observational study in Brazil
por: de Souza, Alexandre Wagner Silva, et al.
Publicado: (2013)

Performance of the 2022 ACR/EULAR giant cell arteritis classification criteria for diagnosis in patients with suspected giant cell arteritis in routine clinical care
por: Molina-Collada, Juan, et al.
Publicado: (2023)

Quantitative ultrasound to monitor the vascular response to tocilizumab in giant cell arteritis
por: Seitz, Luca, et al.
Publicado: (2021)

Giant Cell Arteritis
por: Coulier, Bruno, et al.
Publicado: (2018)

Diagnostic value of axillary artery ultrasound in patients with suspected giant cell arteritis
por: Hop, Hilde, et al.
Publicado: (2020)

Ultrasonographic Halo Score in giant cell arteritis: association with intimal hyperplasia and ischaemic sight loss
por: van der Geest, Kornelis S. M., et al.
Publicado: (2020)

Does the halo count on temporal and axillary ultrasound predict time to relapse in giant cell arteritis?
por: Esperança Almeida, Diogo, et al.
Publicado: (2023)

Clinical Images: Pulmonary Arteritis in Clinically Occult Aneurysmal Giant Cell Arteritis
por: Johnson, Victoria L, et al.
Publicado: (2021)

Markers of angiogenesis and macrophage products for predicting disease course and monitoring vascular inflammation in giant cell arteritis
por: van Sleen, Yannick, et al.
Publicado: (2019)

Design of the Tocilizumab in Giant Cell Arteritis Trial
por: Unizony, Sebastian H., et al.
Publicado: (2013)

Giant Cell Arteritis Presenting as Scalp Necrosis
por: Maidana, Daniel E., et al.
Publicado: (2011)

The crossbow sign in extracranial giant cell arteritis
por: Duret, Pierre‐Marie, et al.
Publicado: (2021)

Temporal swelling: beyond giant cell arteritis
por: Martins-Martinho, Joana, et al.
Publicado: (2023)

Tissue and serum markers of inflammation during the follow-up of patients with giant-cell arteritis—a prospective longitudinal study
por: Visvanathan, Sudha, et al.
Publicado: (2011)

Cardiovascular drug treatment, statins and biopsy-confirmed giant cell arteritis: a population-based case–control study
por: Turkiewicz, Aleksandra, et al.
Publicado: (2020)

Development of revised diagnostic criteria for Fuchs’ uveitis syndrome in a Chinese population
por: Yang, Peizeng, et al.
Publicado: (2022)

Validity of polymyalgia rheumatica diagnoses and classification criteria in primary health care
por: Fors, Charlotta, et al.
Publicado: (2019)

Phenotypic, transcriptomic and functional profiling reveal reduced activation thresholds of CD8(+) T cells in giant cell arteritis
por: Reitsema, Rosanne D, et al.
Publicado: (2022)

Evaluation of the traditional and revised world health organization classifications of dengue cases in Brazil
por: Lima, Fábio Rocha, et al.
Publicado: (2013)

Giant cell arteritis with polymyalgia rheumatica on FDG‐PET/CT
por: Baba, Akira, et al.
Publicado: (2017)

Giant cell arteritis: Its ophthalmic manifestations
por: Hayreh, Sohan Singh
Publicado: (2021)

Ulcer-like Projection Accompanied by Giant Cell Arteritis
por: Otsuka, Yuki, et al.
Publicado: (2020)

Tongue Necrosis: An Atypical Sign of Giant-cell Arteritis
por: Tago, Masaki, et al.
Publicado: (2021)

Patient perceptions of health-related quality of life in giant cell arteritis: international development of a disease-specific patient-reported outcome measure
por: Robson, Joanna C, et al.
Publicado: (2021)

New-onset versus relapsing giant cell arteritis treated with tocilizumab: 3-year results from a randomized controlled trial and extension
por: Stone, John H, et al.
Publicado: (2021)

External validation of the 2022 ACR/EULAR classification criteria in patients with suspected giant cell arteritis in a Dutch fast-track clinic
por: van Nieuwland, Marieke, et al.
Publicado: (2023)

Vasculitis distribution and clinical characteristics in giant cell arteritis: a retrospective study using the new 2022 ACR/EULAR classification criteria
por: Andel, Peter M., et al.
Publicado: (2023)

New classification criteria for systemic lupus erythematosus correlate with disease activity
por: Anić, Felina, et al.
Publicado: (2014)

Giant Cell Arteritis Presenting as Small Bowel Infarction
por: Annamalai, Aniyizhai, et al.
Publicado: (2007)

Giant Cell Arteritis versus Takayasu Arteritis: An Update
por: Stamatis, Pavlos
Publicado: (2020)

Intra-temporalis Muscular Abscess Mimicking Giant Cell Arteritis
por: Kobayashi, Kei, et al.
Publicado: (2021)

Performance of Deauville Criteria in ([18F])FDG-PET/CT Diagnostics of Giant Cell Arteritis
por: Siefert, Jeffrey, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_e4nrubrm2iptjmrhr84qg06g9e